266 related articles for article (PubMed ID: 32278043)
21. Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).
Yu S; Xiong G; Zhao S; Tang Y; Tang H; Wang K; Liu H; Lan K; Bi X; Duan S
Int J Mol Med; 2021 Feb; 47(2):444-454. PubMed ID: 33416134
[TBL] [Abstract][Full Text] [Related]
22. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
23. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
[TBL] [Abstract][Full Text] [Related]
24. The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.
van Dijk N; Funt SA; Blank CU; Powles T; Rosenberg JE; van der Heijden MS
Eur Urol; 2019 Mar; 75(3):435-444. PubMed ID: 30274701
[TBL] [Abstract][Full Text] [Related]
25. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
Pan RY; Chung WH; Chu MT; Chen SJ; Chen HC; Zheng L; Hung SI
J Immunol Res; 2018; 2018():4325874. PubMed ID: 30662919
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for colorectal cancer.
Midgley RS; Kerr DJ
Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
[TBL] [Abstract][Full Text] [Related]
27. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
Liu M; Li L; Jin D; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
[TBL] [Abstract][Full Text] [Related]
28. Neoantigens in the immuno-oncology space.
Arlen PM
Future Oncol; 2017 Oct; 13(25):2209-2211. PubMed ID: 28976211
[No Abstract] [Full Text] [Related]
29. Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets.
Chen C; Liu S; Qu R; Li B
Biomed Res Int; 2020; 2020():2861240. PubMed ID: 32733937
[TBL] [Abstract][Full Text] [Related]
30. The perfect personalized cancer therapy: cancer vaccines against neoantigens.
Aurisicchio L; Pallocca M; Ciliberto G; Palombo F
J Exp Clin Cancer Res; 2018 Apr; 37(1):86. PubMed ID: 29678194
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy in hepatocellular carcinoma.
Buonaguro L; Mauriello A; Cavalluzzo B; Petrizzo A; Tagliamonte M
Ann Hepatol; 2019; 18(2):291-297. PubMed ID: 31047849
[TBL] [Abstract][Full Text] [Related]
32. Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.
Iezzi ME; Policastro L; Werbajh S; Podhajcer O; Canziani GA
Front Immunol; 2018; 9():273. PubMed ID: 29520274
[TBL] [Abstract][Full Text] [Related]
33. Colorectal Cancer Immunotherapy: Options and Strategies.
Johdi NA; Sukor NF
Front Immunol; 2020; 11():1624. PubMed ID: 33042104
[TBL] [Abstract][Full Text] [Related]
34. Neoantigen vaccine: an emerging tumor immunotherapy.
Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
[TBL] [Abstract][Full Text] [Related]
35. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
36. Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy.
Piramoon M; Khodadust F; Hosseinimehr SJ
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188529. PubMed ID: 33647388
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic cancer vaccines: From initial findings to prospects.
Song Q; Zhang CD; Wu XH
Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
[TBL] [Abstract][Full Text] [Related]
38. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
Kather JN; Halama N; Jaeger D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
[TBL] [Abstract][Full Text] [Related]
39. Nanobody-based cancer therapy of solid tumors.
Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
[TBL] [Abstract][Full Text] [Related]
40. Dendritic Cells and Their Role in Immunotherapy.
Gardner A; de Mingo Pulido Á; Ruffell B
Front Immunol; 2020; 11():924. PubMed ID: 32508825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
